Evidence map›Paper›PMID 16407117›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.

Chia-Lin Hsu, Angela G King-Fleischman, Anne Y Lai, Yukie Matsumoto, Irving L Weissman, Motonari Kondo

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. C/EBPα in normal and malignant myelopoiesis.International journal of hematology · 2015
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chia-Lin HsuDepartment of Immunology, Duke University Medical Center, DUMC 3010, Research Drive, Durham, NC 27710, USA.
Angela G King-Fleischman
Anne Y Lai
Yukie Matsumoto
Irving L Weissman
Motonari Kondo
Duke Medical Center · USDuke University Hospital · US

Funding

Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
IL-7 receptor signaling in lymphopoiesisR01AI056123 · NIAID · DUKE UNIVERSITY · PI KONDO, MOTONARI · 2004 to 2010
$2.1M
THYMIC LYMPHOCYTE DEVELOPMENTR01AI047457 · NIAID · STANFORD UNIVERSITY · PI WEISSMAN, IRVING LERNER · 2000 to 2004
$1.6M
BIOLOGY AND TRANSPLANTATION OF CLPR01AI047458 · NIAID · STANFORD UNIVERSITY · PI WEISSMAN, IRVING LERNER · 2001 to 2005
$1.5M
Commitment mechanisms in hemato/lymphopoiesisR01CA098129 · NCI · DUKE UNIVERSITY · PI KONDO, MOTONARI · 2004 to 2008
$1.4M
NCI NIH HHS R01 CA098129NCI NIH HHS R01 CA42551NIAID NIH HHS R01 AI047457NIAID NIH HHS R01 AI047458NIAID NIH HHS R01 AI056123NIAID NIH HHS R01 AI47457NIAID NIH HHS R01 AI47458NIAID NIH HHS T32 AI052077NIAID NIH HHS T32 AI52077
6 · The paper itself

Abstract

Lymphoid lineage-committed progenitors, such as common lymphoid progenitors (CLPs), maintain a latent myeloid differentiation potential, which can be initiated by stimulation through exogenously expressed cytokine receptors, including IL-2 receptors. Here we show that the transcription factor CCAAT enhancer-binding protein-alpha (C/EBPalpha) is promptly up-regulated in CLPs upon ectopic IL-2 stimulation. Enforced C/EBPalpha expression is sufficient to initiate myeloid differentiation from CLPs, as well as from proT and proB cells, even though proB cells do not give rise to myeloid cells after ectopic IL-2 stimulation. Expression of Pax5, a B lymphoid-affiliated transcription factor, is completely suppressed by enforced C/EBPalpha but not by ectopic IL-2 stimulation in proB cells. Introduction of Pax5 blocks ectopic IL-2 receptor-mediated myeloid lineage conversion in CLPs. These data suggest that C/EBPalpha is a proximal target of cytokine-induced lineage conversion in lymphoid progenitors. Furthermore, complete loss of Pax5 expression triggered by up-regulation of C/EBPalpha is a critical event for lineage conversion from lymphoid to myeloid lineage in CLPs and proB cells.

Indexed as

AnimalsCCAAT-Enhancer-Binding Protein-alphaCell DifferentiationCell LineageCells, CulturedDown-RegulationHumansInterleukin-2 Receptor beta SubunitLymphocytesMiceMice, Inbred C57BLMice, TransgenicMyeloid CellsPAX5 Transcription FactorReceptors, Interleukin-2Signal TransductionCCAAT-Enhancer-Binding Protein-alphaIL2RB protein, humanIl2rb protein, mouseInterleukin-2 Receptor beta SubunitPax5 protein, mousePAX5 Transcription FactorReceptors, Interleukin-2

Identifiers

PMID16407117
PMCPMC1334685
OpenAlexW2158313095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.